SESN2 and endometrium neoplasm: For example, a study of primary endometrial tumours showed that SESN2 expression was correlated with lower patient survival, and mTORC1 activity levels were higher in these tumours in the presence of Sestrins, suggesting dysfunctional Sestrin–mTORC1 signalling [79].